| 25108-36-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• CAS: 25108-36-5
• 化学式: C6H5KNO2
• 分子量: 162.21
• InChiKey: IKSZSMBKENHSFA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.4
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  50.2
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 海关编码：
  2933399090

文献信息

• Compositions and methods for prevention and treatment of chronic diseases and disorders including the complications of diabetes mellitus
  申请人：——

  公开号：US20010031744A1

  公开（公告）日：2001-10-18

  This invention relates to nutrient and therapeutic compositions for treatment and prevention of symptoms and disease conditions associated with microangiopathy and macroangiopathy and to methods using the compositions. In particular, the invention relates to compositions useful in the treatment of diabetic retinopathy and nephropathy, to compositions useful in the treatment of other retinal disorders including macular degeneration and cataracts, to compositions useful in wound healing, to compositions useful for treatment and prevention of neuropathy, to compositions useful for treatment and prevention of cardiovascular disease and to compositions useful for the treatment and prevention of dental and periodontal disorders.

  这项发明涉及用于治疗和预防与微血管病和大血管病相关的症状和疾病状况的营养和治疗组合物，以及使用这些组合物的方法。具体来说，该发明涉及用于治疗糖尿病视网膜病和肾病的组合物，用于治疗其他视网膜疾病包括黄斑变性和白内障的组合物，用于伤口愈合的组合物，用于治疗和预防神经病变的组合物，用于治疗和预防心血管疾病的组合物，以及用于治疗和预防口腔和牙周疾病的组合物。
• Appetite suppressant compositions and methods thereof
  申请人：Red Mountain Holdings, LLC

  公开号：US11344556B2

  公开（公告）日：2022-05-31

  In various embodiments an appetite suppressant composition comprises at least one anorectic active ingredient (AAI); at least one of a nutritive substance, a controlled drug delivery agent (CDRA), and a cofactor; and optionally, an excipient. The AIA may comprise any one of phentermine, phendimetrazine, diethylpropion, naltrexone, and bupropion. The CDRA may comprise a cellulosic. The cofactor may comprise a chromium or selenium salt. In various embodiments, the compositions herein are provided in an oral capsule dosage form for GI-tract administration of the AAI. A method of suppressing appetite in individuals in need thereof are described.

  在各种实施方案中，食欲抑制剂组合物包括至少一种厌食症活性成分（AAI）；营养物质、控制给药剂（CDRA）和辅助因子中的至少一种；以及可选的赋形剂。AIA可包括芬特明、芬地美曲秦、地特丙酮、纳曲酮和安非他酮中的任意一种。CDRA 可包括纤维素。辅助因子可包括铬盐或硒盐。在各种实施方案中，本文中的组合物以口服胶囊剂型提供，用于胃肠道给药 AAI。描述了一种抑制需要者食欲的方法。
• Carbonated fortified milk-based beverage and method for suppressing bacterial growth in the beverage
  申请人：——

  公开号：US20030113408A1

  公开（公告）日：2003-06-19

  Dairy or non-diary based fortified carbonated beverage solutions that supply essential nutrients in the human diet. The solution contains per 354 ml, calcium, magnesium and potassium ions in the form of salts and optionally vitamins A, D, C, lutein, zeaxanthin and folic acid in specified amounts to provide dietary supplementation. Sweeteners, stabilizers, flavors and carbonation can also be added to enhance flavor, taste, mouth-feel, ingredient solubilization and product appearance. A method of making the beverages is also described. A method of using carbonation to reduce bacterial counts and reduce degradation of essential nutrients in milk-based beverages with or without pasteurization is also disclosed.

  以乳制品或非乳制品为基础的强化碳酸饮料溶液，可提供人类饮食中必需的营养成分。每 354 毫升溶液中含有盐形式的钙、镁和钾离子，以及规定量的维生素 A、D、C、叶黄素、玉米黄质和叶酸，以提供膳食补充。此外，还可添加甜味剂、稳定剂、香精和碳酸剂，以增强风味、口感、配料溶解度和产品外观。此外，还介绍了制作饮料的方法。此外，还公开了一种利用碳酸化减少细菌数量和降低牛奶饮料中必需营养成分降解的方法，无论是否经过巴氏杀菌。
• Amino acid chelate for the effective supplementation of calcium magnesium and potassium in the human diet
  申请人：——

  公开号：US20030228347A1

  公开（公告）日：2003-12-11

  Amino acid chelates for enhancing the absorption and assimilation of essential minerals in the human diet. Calcium, magnesium and potassium picolinic acid salts are disclosed as food and beverage supplements to improve the nutritive capacity of food stuffs and beverages. A method of enhancing the nutritive value of food and beverages is also described.

  氨基酸螯合物，用于促进人类饮食中必需矿物质的吸收和同化。本研究公开了作为食品和饮料补充剂的钙、镁和钾吡啶甲酸盐，以提高食品和饮料的营养能力。还介绍了一种提高食品和饮料营养价值的方法。
• DIETARY SUPPLEMENTS COMPRISING VITAMINS AND MINERALS
  申请人：LifeScience Corporation

  公开号：EP0514451B1

  公开（公告）日：1997-01-15